|

Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools

RECRUITINGSponsored by Ju Qiu
Actively Recruiting
SponsorJu Qiu
Started2023-08-12
Est. completion2025-12-30
Eligibility
Age50 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06467149

Summary

This study uses the Physical Frailty Phenotype (PFP) as the diagnostic criterion for frailty and aims to explore the frailty screening scale FRAIL (The FRAIL Scale), Tilburg Frailty Index (TFI) and geriatric screening. Screening performance of Tool-8 (Geriatric-8, G-8) in breast cancer patients, to compare the predictive validity of different frailty screening scales for adverse health outcomes in breast cancer patients, and to select appropriate frailty screening methods for breast cancer patients in my country Screening scale.

Eligibility

Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria:

* Clinical diagnosis of breast cancer
* Age ≥50 years old
* the treatment plan discussed by MDT includes surgery and chemotherapy
* can walk on their own (with the assistance of walking aids)

Exclusion Criteria:

* Communication disorders
* Mental disorders that can't cooperate normally
* Combined with other malignant tumours
* Terminal stage of the disease

Conditions3

Breast CancerCancerFrailty Syndrome

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.